Jefferies Initiates Coverage On Beta Bionics with Buy Rating, Announces Price Target of $30

Benzinga · 2d ago
Jefferies analyst Michael Toomey initiates coverage on Beta Bionics (NASDAQ:BBNX) with a Buy rating and announces Price Target of $30.